The new WHO classification of adrenal cortical proliferations reflects translational advances
in the fields of endocrine pathology, oncology and molecular biology. By adopting a …

Adrenocortical carcinoma (ACC) is an orphan malignancy that has attracted increasing
attention during the last decade. Here we provide an update on advances in the field since …

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …

The introduction of Ki67 immunohistochemistry in the work-up of neuroendocrine neoplasms
(NENs) has opened a new approach for their diagnosis and prognostic evaluation. Since the …

Adrenocortical carcinoma (ACC) is a heterogenous group of diseases with different clinical
behaviour between adult and paediatric patients. In addition, three histological variants …

Approximately one-tenth of the general population exhibit adrenal cortical nodules, and the
incidence has increased. Afflicted patients display a multifaceted symptomatology …

Breast cancer is the most prevalent type of cancer in women and responsible for significant
female cancer-related mortality worldwide. In the Western world, over 80% of breast cancers …

Adrenocortical carcinoma patient prognosis is extremely variable and poorly predictable.
The newly introduced Helsinki Score is the first so far proposed diagnostic and prognostic …

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. ACC is capable
of secreting excess adrenocortical hormones, which can compound morbidity and …

The diagnosis of low-grade adrenal cortical carcinoma (ACC) confined to the adrenal gland
can be challenging. Although there are diagnostic and prognostic molecular tests for ACC …